Reuters reports Wednesday that a volunteer has died in Brazil during a test of the AstraZeneca vaccine-19 vaccine.
The information came from an investigation into the death of Anvisa, a Brazilian health official.
It is not clear whether the volunteer received the vaccine or received a placebo shot.
A participant in a study in the United Kingdom was diagnosed with a spinal cord injury and had a stage 3 clinical trial of Astrogeneka suspended in early September. Tests have resumed in the UK and Brazil Would have been suspended in the United States
The vaccine candidate is being developed with the University of Oxford.
AstraZeneca said in a statement to NBC News that the case would continue.
“During the ongoing investigation of the Oxford vaccine we are unable to comment on individual cases because we strictly adhere to the rules of medical confidentiality and clinical testing, but we can ensure that all necessary review procedures have been followed,” the statement said. “All significant clinical cases are carefully evaluated by probation investigators, an independent safety monitoring group and regulatory authorities. These assessments raise no concerns about continuing the study.”
This is a growing story, check back for updates.